![[dr. bob]](/dr-bob-sm.gif)
Dr. Bob is Robert Hsiung, MD,
[email protected]Shown: posts 1 to 3 of 3. This is the beginning of the thread.
Posted by jparsell82 on September 9, 2009, at 20:29:02
http://www.reuters.com/article/pressRelease/idUS164893+03-Sep-2009+PRN20090903
"INTUNIV, the first nonscheduled alpha-2A receptor agonist indicated for ADHD,
demonstrated improvement in a range of ADHD symptoms that can be disruptive,
such as inattention, arguing with adults, hyperactivity, impulsivity, and
losing one's temper""Once-daily INTUNIV is expected to be available in US pharmacies in November
and will come in four dosage strengths (1 mg, 2 mg, 3 mg, and 4 mg). INTUNIV
will be marketed in the United States by the existing Shire ADHD sales team of
nearly 600 representatives. INTUNIV is not a controlled substance and has no
known potential for abuse or dependence.( )"I'm curious as to how this would combine with stimulants. Anyone ever tried Guanfacine under the brand Tenex?
Posted by jparsell82 on September 9, 2009, at 20:31:12
In reply to Intuniv in November for ADHD, posted by jparsell82 on September 9, 2009, at 20:29:02
whoops wrong forum
Posted by desolationrower on September 20, 2009, at 3:26:23
In reply to Intuniv in November for ADHD, posted by jparsell82 on September 9, 2009, at 20:29:02
>
> "INTUNIV, the first nonscheduled alpha-2A receptor agonist indicated for ADHD,lol@implying other a2a agonists are scheduled
> I'm curious as to how this would combine with stimulants. Anyone ever tried Guanfacine under the brand Tenex?
>
it might help, i'd probably take it in the evening. no need to take this $$ version tho-d/r
This is the end of the thread.
Psycho-Babble Neurotransmitters | Extras | FAQ
Dr. Bob is Robert Hsiung, MD,
[email protected]
Script revised: February 4, 2008
URL: http://www.dr-bob.org/cgi-bin/pb/mget.pl
Copyright 2006-17 Robert Hsiung.
Owned and operated by Dr. Bob LLC and not the University of Chicago.